SINGLE-CHANNEL CHARACTERIZATION OF THE PHARMACOLOGICAL PROPERTIES OF THE K(CA2-CELLS() CHANNEL OF INTERMEDIATE CONDUCTANCE IN BOVINE AORTICENDOTHELIAL)
S. Cai et al., SINGLE-CHANNEL CHARACTERIZATION OF THE PHARMACOLOGICAL PROPERTIES OF THE K(CA2-CELLS() CHANNEL OF INTERMEDIATE CONDUCTANCE IN BOVINE AORTICENDOTHELIAL), The Journal of membrane biology, 163(2), 1998, pp. 147-158
The pharmacological profile of a voltage-independent Ca2+-activated po
tassium channel of intermediate conductance (IK(Ca2+)) present in bovi
ne aortic endothelial cells (BAEC) was investigated in a series of ins
ide-out and outside-out patch-clamp experiments. Channel inhibition wa
s observed in response to external application of ChTX with a half inh
ibition concentration of 3.3 +/- 0.3 nM (n = 4). This channel was inse
nsitive to IbTX, but channel block was detected following external app
lication of MgTX and StK leading to the rank order toxin potency ChTX
> StK > MgTX >>IbTX. A reduction of the channel unitary current amplit
ude was also measured in the presence of external TEA, with half reduc
tion occurring at 23 +/- 3 mM TEA (n = 3). The effect of TEA was volta
ge insensitive, an indication that TEA may bind to a site located on e
xternal side of the pore region of this channel. Similarly, the additi
on of d-TC to the external medium caused a reduction of the channel un
itary current amplitude with half reduction at 4.4 +/- 0.3 mM (n = 4).
In contrast, application of d-TC to the bathing medium in inside-out
experiments led to the appearance of long silent periods, typical of a
slow blocking process. Finally, the IK(Ca2+) in BAEC was found to be
inhibited by NS1619, an activator of the Ca2+-activated potassium chan
nel of large conductance (Maxi K(Ca2+)), with a half inhibition value
of 11 +/- 0.8 mu M (n = 4). These results provide evidence for a pharm
acological profile distinct from that reported for the Maxi K(Ca2+) ch
annel, with some features attributed to the voltage-gated K(v)1.2 pota
ssium channel.